These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18682248)

  • 1. Novel anti-HIV peptides containing multiple copies of artificially designed heptad repeat motifs.
    Shi W; Qi Z; Pan C; Xue N; Debnath AK; Qie J; Jiang S; Liu K
    Biochem Biophys Res Commun; 2008 Oct; 374(4):767-72. PubMed ID: 18682248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationally designed anti-HIV peptides containing multifunctional domains as molecule probes for studying the mechanisms of action of the first and second generation HIV fusion inhibitors.
    Qi Z; Shi W; Xue N; Pan C; Jing W; Liu K; Jiang S
    J Biol Chem; 2008 Oct; 283(44):30376-84. PubMed ID: 18662985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides.
    Liu S; Jing W; Cheung B; Lu H; Sun J; Yan X; Niu J; Farmar J; Wu S; Jiang S
    J Biol Chem; 2007 Mar; 282(13):9612-9620. PubMed ID: 17276993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of resistance to S138A substituted enfuvirtide and its application to peptide design.
    Izumi K; Kawaji K; Miyamoto F; Shimane K; Shimura K; Sakagami Y; Hattori T; Watanabe K; Oishi S; Fujii N; Matsuoka M; Kaku M; Sarafianos SG; Kodama EN
    Int J Biochem Cell Biol; 2013 Apr; 45(4):908-15. PubMed ID: 23357451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.
    Su S; Zhu Y; Ye S; Qi Q; Xia S; Ma Z; Yu F; Wang Q; Zhang R; Jiang S; Lu L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120.
    Liu S; Lu H; Niu J; Xu Y; Wu S; Jiang S
    J Biol Chem; 2005 Mar; 280(12):11259-73. PubMed ID: 15640162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain.
    Lu L; Tong P; Yu X; Pan C; Zou P; Chen YH; Jiang S
    Biochim Biophys Acta; 2012 Dec; 1818(12):2950-7. PubMed ID: 22867851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent anti-HIV-1 activity of N-HR-derived peptides including a deep pocket-forming region without antagonistic effects on T-20.
    Izumi K; Watanabe K; Oishi S; Fujii N; Matsuoka M; Sarafianos SG; Kodama EN
    Antivir Chem Chemother; 2011 Aug; 22(1):51-5. PubMed ID: 21860071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing hydrophobicity of residues in an anti-HIV-1 Env peptide synergistically improves potency.
    Leung MY; Cohen FS
    Biophys J; 2011 Apr; 100(8):1960-8. PubMed ID: 21504732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors.
    Zhu Y; Ding X; Yu D; Chong H; He Y
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of Gln64 in the HIV-1 gp41 N-terminal heptad repeat render viruses resistant to peptide HIV fusion inhibitors targeting the gp41 pocket.
    Yu X; Lu L; Cai L; Tong P; Tan S; Zou P; Meng F; Chen YH; Jiang S
    J Virol; 2012 Jan; 86(1):589-93. PubMed ID: 22013063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
    Gustchina E; Hummer G; Bewley CA; Clore GM
    J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitro.
    Chang CH; Hinkula J; Loo M; Falkeborn T; Li R; Cardillo TM; Rossi EA; Goldenberg DM; Wahren B
    PLoS One; 2012; 7(7):e41235. PubMed ID: 22844444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different susceptibility of human immunodeficiency virus type 1 to Env gp41-derived synthetic peptides corresponding to the C-terminal heptad repeat region.
    N A PI; Li GM; Warachit J; Iwabu Y; Tsuji S; Auwanit W; Yamamoto D; Goto T; Hayashi Y; Kiso Y; Ikuta K
    Microbes Infect; 2005 Mar; 7(3):356-64. PubMed ID: 15780966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 gp41 heptad repeat 2 (HR2) possesses an amino acid domain that resembles the allergen domain in Aspergillus fumigatus Asp f1 protein: review, hypothesis and implications.
    Becker Y
    Virus Genes; 2007 Jun; 34(3):233-40. PubMed ID: 17333401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of highly potent HIV fusion inhibitors based on artificial peptide sequences.
    Shi W; Cai L; Lu L; Wang C; Wang K; Xu L; Zhang S; Han H; Jiang X; Zheng B; Jiang S; Liu K
    Chem Commun (Camb); 2012 Dec; 48(94):11579-81. PubMed ID: 23093045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains.
    He Y; Cheng J; Lu H; Li J; Hu J; Qi Z; Liu Z; Jiang S; Dai Q
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16332-7. PubMed ID: 18852475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrostatically constrained alpha-helical peptide inhibits replication of HIV-1 resistant to enfuvirtide.
    Nishikawa H; Nakamura S; Kodama E; Ito S; Kajiwara K; Izumi K; Sakagami Y; Oishi S; Ohkubo T; Kobayashi Y; Otaka A; Fujii N; Matsuoka M
    Int J Biochem Cell Biol; 2009 Apr; 41(4):891-9. PubMed ID: 18834950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection.
    Bianchi E; Finotto M; Ingallinella P; Hrin R; Carella AV; Hou XS; Schleif WA; Miller MD; Geleziunas R; Pessi A
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12903-8. PubMed ID: 16129831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The LLSGIV stretch of the N-terminal region of HIV-1 gp41 is critical for binding to a model peptide, T20.
    Trivedi VD; Cheng SF; Wu CW; Karthikeyan R; Chen CJ; Chang DK
    Protein Eng; 2003 Apr; 16(4):311-7. PubMed ID: 12736375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.